Use of brimonidine tartrate to resolve telangiectatic matting: case report

Sclerotherapy is currently the treatment of choice for telangiectasias and reticular veins, with grade 1A recommendation in the European Guideline for sclerotherapy. The most common side effects of this procedure are hyperpigmentation and telangiectatic matting, the second of which provokes great co...

Descripción completa

Detalles Bibliográficos
Autores principales: de Mello, Brenno Augusto Seabra, Beiriz, Yasmin de Rezende, Bonatto, Américo Carnelli, Maciel, Gustavo Sasso Benso, de Almeida, Laila Reggiani, Corassa, José Marcelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Angiologia e de Cirurgia Vascular (SBACV) 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276647/
https://www.ncbi.nlm.nih.gov/pubmed/34290750
http://dx.doi.org/10.1590/1677-5449.190159
Descripción
Sumario:Sclerotherapy is currently the treatment of choice for telangiectasias and reticular veins, with grade 1A recommendation in the European Guideline for sclerotherapy. The most common side effects of this procedure are hyperpigmentation and telangiectatic matting, the second of which provokes great concern because of the esthetic damage and the difficulty of treatment. Matting refers to vessels with a diameter of less than 0.2 mm, which may emerge irregularly or in well-defined areas, especially on the lower limbs. This report presents a case of matting treated with topical Brimonidine Tartrate.

Ejemplares similares